Jacob A. Frenkel's most recent trade in Brainstorm Cell Therapeutics, Inc. was a trade of 40,000 Common Stock done . Disclosure was reported to the exchange on Jan. 1, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Brainstorm Cell Therapeutics | Jacob A. Frenkel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2025 | 40,000 | 43,777 (0%) | 0% | 0 | Common Stock | |
| Brainstorm Cell Therapeutics | Jacob A. Frenkel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Apr 2022 | 50,000 | 50,000 | - | - | Stock Option (right to buy) |